메뉴 건너뛰기




Volumn 878, Issue 9-10, 2010, Pages 749-757

Development and validation of a method for the determination of a therapeutic peptide with affinity for the human B1 receptor in human plasma using HPLC-MS/MS

Author keywords

96 well SPE; Absorption; HPLC MS MS; Peptide; SPE

Indexed keywords

96-WELL; 96-WELL PLATE; 96-WELL SPE; APPLIED BIOSYSTEMS; CHRONIC PAIN; CLINICAL TRIAL; COEFFICIENTS OF VARIATIONS; CONCENTRATION RANGES; CV VALUE; HPLC-MS/MS; HUMAN PLASMAS; INTERNAL STANDARDS; ISOTOPICALLY LABELED; PLASMA SAMPLES; SYNTHETIC PEPTIDE; THERAPEUTIC PEPTIDES;

EID: 77549088269     PISSN: 15700232     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jchromb.2010.01.018     Document Type: Article
Times cited : (16)

References (16)
  • 12
    • 0005905707 scopus 로고    scopus 로고
    • Food and Drug Administration Guidance for Industry:, U.S. Department of Health and Human Services, FDA Center for Drug Evaluation and Research CDER, Rockville, Maryland
    • Food and Drug Administration Guidance for Industry: Bioanalytical Method Validation, U.S. Department of Health and Human Services, FDA Center for Drug Evaluation and Research (CDER), Rockville, Maryland, 2001.
    • (2001) Bioanalytical Method Validation


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.